TransMedics Q4 net income hits USD 105.4 million on a FY effective tax rate of (77.0)%

Reuters
02/27
TransMedics Q4 net income hits USD 105.4 million on a FY effective tax rate of (77.0)%

TransMedics said it released a USD 103.3 million U.S. tax valuation allowance in Q4 2025, resulting in a net income tax benefit of USD 83.8 million. For Q4 2025, TransMedics reported income before income taxes of USD 21.6 million, net income of USD 105.4 million and diluted EPS of USD 2.62. The company said its FY 2025 effective tax rate was (77.0)% and that, excluding the valuation allowance release, the FY 2025 effective tax rate was 19.1%. TransMedics added that it expects future quarterly income tax provisions to be more in line with U.S. statutory corporate income tax rates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602270700PR_NEWS_USPR_____NE97440) on February 27, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10